Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression

@article{VidalVanaclocha2006ClinicalAE,
  title={Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression},
  author={Fernando Vidal-Vanaclocha and Lorea Mendoza and Naiara Teller{\'i}a and Clarisa Salado and Mar{\'i}a A Valc{\'a}rcel and Natalia Gallot and Teresa Carrascal and Eider Egilegor and Jabier Beaskoetxea and Charles A Dinarello},
  journal={Cancer and Metastasis Reviews},
  year={2006},
  volume={25},
  pages={417-434}
}
Interleukin-18 (IL-18, interferon [IFN]-gamma-inducing factor) is a proinflammatory cytokine converted to a biologically active molecule by interleukin (IL)-1beta converting enzyme (caspase-1). A wide range of normal and cancer cell types can produce and respond to IL-18 through a specific receptor (IL-18R) belonging to the toll-like receptor family. The activity of IL-18 is regulated by IL-18-binding protein (IL-18bp), a secreted protein possessing the ability to neutralize IL-18 and whose… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 51 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 97 references

Interleukin-18 upregulates very late antigen-4 expression from melanoma cell variants of low intracellular glutathione content, via oxidative stress-induced autocrine tumor necrosis factor-alpha

  • N. Telleria, T. Carrascal, J. Beaskoetxea, C. Salado, E. Egilegor, L Mendoza
  • Cancer Research
  • 2006
Highly Influential
3 Excerpts

Interleukin-18 mediates proangiogenic action of vascular endothelial growth factor on myofibroblast and endothelial cell recruitment into hepatic melanoma metastasis. Hepatology

  • L. Mendoza, V. Gutierrez, T. Carrascal, M. Valcárcel, C. A. Dinarello, F. Vidal-Vanaclocha
  • Cancer Metastasis Rev
  • 2006
1 Excerpt

Similar Papers

Loading similar papers…